Toggle Side Panel

Tag: WearableTech

{"hide_search_input":"0","hide_near_input":"1","input_size":"","bar_flex_wrap":"","bar_flex_wrap_md":"","bar_flex_wrap_lg":"","input_border":"","input_border_opacity":"","input_rounded_size":"","btn_bg":"dark","btn_rounded_size":"","btn_rounded_size_md":"","btn_rounded_size_lg":"","bg":"","mt":"","mr":"","mb":"3","ml":"","pt":"","pr":"","pb":"","pl":"","border":"","rounded":"","rounded_size":"","rounded_size_md":"","rounded_size_lg":"","shadow":"","css_class":""}
GreenTech / Sustainability

Eco-Friendly Energy Storage for IoT & Smart Devices

This cleantech company designs and manufactures ultra-thin, sustainable supercapacitors for powering wireless IoT devices—offering a greener, safer, and maintenance-free alternative to traditional lithium-ion batteries. Focus areas include smart buildings, asset tracking, electronic shelf labels, and smart cards. Read more ...
Project Region: Sweden
Fund Stage: Series A
Problem and Solution:

Problem
– Billions of IoT devices require sustainable and cost-effective energy solutions
– Lithium-ion batteries are hazardous, bulky, and unsustainable for next-gen IoT

Solution
– Ultra-thin, recyclable supercapacitors powered by solar, RF, or vibration
– Enables zero-maintenance, environmentally safe power at low cost
– Integrates easily with modern sensors, labels, and printed electronics

Project Region: Sweden
Raise Size (Estimated in USD): 5M to 10M
Deep Tech / Biotech

Next-Gen Diagnostics for Stroke & Alzheimer’s Risk

A health-tech startup building a low-cost, non-invasive diagnostic tool to detect biomarkers linked to stroke and Alzheimer’s disease risk through saliva. The platform also incubates next-gen medical researchers, enabling innovation in cerebrovascular and neurodegenerative disease diagnostics. The tool is enhanced by AI analytics and aims to deliver mass-market screening, even Read more ...
Project Region: Australia
Fund Stage: Pre-Seed
Problem and Solution:

Problem: Stroke is the 2nd leading cause of global mortality. Current diagnostics are either costly, invasive, or reactive. Alzheimer’s remains undetected until late-stage symptoms appear.

Solution: This platform uses AI to analyze non-invasive enzyme signals from saliva—delivering affordable, scalable screening at the pre-symptomatic stage. It also trains and funds medical innovators to fast-track new neurodiagnostic solutions to market.

Project Region: Australia
Raise Size (Estimated in USD): 500K to 1M

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .